EximRx turns customs records into pharma market data.
EximRx is a pharmaceutical market intelligence service from Rxquad FZC, a company registered in Sharjah Publishing City Free Zone, United Arab Emirates. We turn the customs records that countries publish into one structured database of molecules, companies, therapy classes and markets.
Pharma commercial specialists.
Our background is the commercial side of pharma. We know how a commercial team sizes a market, tracks its competitors and chooses where to launch.
We also know the markets EximRx covers and the problems teams meet there: little audited data, many local importers, and products filed under names that differ from one shipment to the next.
Why we built EximRx.
To close the data gap in these markets
In 41 of the 53 markets we cover, the sales audit is missing or partial. Teams deciding on these markets have had little data to work with.
To turn the data into decisions
Customs records exist for each of these markets, but they are hard to use. We organise them so a commercial team can ask how large a market is, who supplies it and who buys.
To apply AI to one business task
We use AI for a defined job: reading millions of filings and classifying them the way pharma does. Pharmaceutical rules check what it returns.
How we treat data.
Comparable first
We standardise records before we add more of them, so that each market can be compared with the others.
The industry's structure
Records are organised by molecule, corporate group and therapy class, the way pharma teams already work.
Open records
You can open any figure and see the filings behind it.
Stated limits
We say where trade data is strong and where it needs care.